Director/PDMR Shareholding

RNS Number : 6860P
Rentokil Initial PLC
21 June 2022
 

Rentokil Initial plc (the "Company")

21 June 2022

 

Notification of transactions by a person closely associated with persons discharging managerial responsibilities

 

The Company hereby announces that a person closely associated Brian Webb, Group Operations Excellence Director and a person discharging managerial responsibilities (PDMR), has purchased ordinary shares in the Company.

 

The relevant notification set out below is provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

Alexandra Webb

2

 

Reason for the notification

 

a)

 

Position/status

 

A person closely associated with Brian Webb, Group Operations Excellence Director (PDMR)

 

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Rentokil Initial plc

b)

 

LEI

 

549300VN4WV7Z6T14K68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 1p each

 

 

ISIN: GB00B082RF11

b)

 

Nature of the transaction

 

Purchase of shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£4.46

11,124

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

- Total

 

 

 

11,124

 

£4.46

 

£49,613.04

e)

 

Date of the transaction

 

21 June 2022

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

 

Enquiries:

 

Catherine Stead, Company Secretary  Rentokil Initial plc 07826 533700

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBSGDLLXDDGDB
UK 100